Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
نویسندگان
چکیده
Mebendazole, a well-known anti-helminthic drug in wide clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical studies across a number of different cancer types. Significantly, there are also two case reports of anti-cancer activity in humans. The data are summarised and discussed in relation to suggested mechanisms of action. Based on the evidence presented, it is proposed that mebendazole would synergise with a range of other drugs, including existing chemotherapeutics, and that further exploration of the potential of mebendazole as an anti-cancer therapeutic is warranted. A number of possible combinations with other drugs are discussed in the Appendix.
منابع مشابه
Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
Cimetidine, the first H2 receptor antagonist in widespread clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical and clinical studies for a number of different cancer types. These data are summarised and discussed in relation to a number of distinct mechanisms of action. Based on the evidence presented, it is proposed that cimetidine would synergise...
متن کاملRepurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has evidence of clinical activity that is of interest in oncology. There is evidence that at the clinically relevant doses, itraconazole has potent anti-angiogenic activity, and that it can inhibit the Hedgehog signalling pathway and may also induce autophagic growth arrest. The evidence for these anticancer effects, i...
متن کاملThe Repurposing Drugs in Oncology (ReDO) Project
The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outline...
متن کاملNovel Candidate Identification Stratagies
Nazir, M. 2018. Drug Repositioning for Cancer Treatment. Novel Candidate Identification Stratagies. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1416. 40 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0203-4. Regardless of the enormous investments in cancer research and drug development, the proportion of approved drugs in oncology is low c...
متن کاملRepurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
Clarithromycin (CAM) is a well-known macrolide antibiotic available as a generic drug. CAM is traditionally used for many types of bacterial infections, treatment of Lyme disease and eradication of gastric infection with Helicobacter pylori. Extensive preclinical and clinical data demonstrate a potential role for CAM to treat various tumours in combination with conventional treatment. The mecha...
متن کامل